This cholesterol-cutting drug peaked in 2006 with nearly $ 13 billion in annual sales but will lose its patent protection in 2011 , when generic versions will become available . `` It is our policy not to comment on rumor or speculation , '' Wyeth rep says . R & D was not immediately available for comment . Pfizer said January 13 it was cutting 12 percent , or about 800 jobs , of its Pfizer staff .
`` It is our policy not to comment on rumor or speculation , '' Wyeth rep says . R & D was not immediately available for comment . Pfizer said January 13 it was cutting 12 percent , or about 800 jobs , of its Pfizer staff .